Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Lithium citrate
Drug ID BADD_D02522
Description Not Available
Indications and Usage Lithium is used as a mood stabilizer, and is used for treatment of depression and mania. It is often used in bipolar disorder treatment.
Marketing Status Not Available
ATC Code N05AN01
DrugBank ID DB14507
KEGG ID D04749
MeSH ID C070669
PubChem ID 13520
TTD Drug ID Not Available
NDC Product Code Not Available
Synonyms lithium citrate | Litarex | monolithium citrate
Chemical Information
Molecular Formula C6H5Li3O7
CAS Registry Number 919-16-4
SMILES [Li+].[Li+].[Li+].C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Insomnia19.02.01.002; 17.15.03.002-
Intention tremor17.01.06.005-Not Available
Intentional self-injury19.12.01.002; 12.01.08.036-Not Available
Intracranial pressure increased17.07.02.002-Not Available
Irritability08.01.03.011; 19.04.02.013--
Lethargy19.04.04.004; 17.02.04.003; 08.01.01.008-
Leukocytosis01.02.01.002-
Leukopenia01.02.02.001--Not Available
Loss of consciousness17.02.04.004-Not Available
Malaise08.01.01.003--
Mania19.16.02.002-
Memory impairment19.20.01.003; 17.03.02.003-
Mental impairment19.21.02.003; 17.03.03.002-Not Available
Metabolic acidosis14.01.01.003-Not Available
Multiple sclerosis17.16.01.001; 10.04.10.008-Not Available
Muscle rigidity17.05.02.005; 15.05.04.001-Not Available
Muscle spasms15.05.03.004--
Muscular weakness17.05.03.005; 15.05.06.001--
Myalgia15.05.02.001--
Myocarditis02.04.03.001-
Myoclonus17.02.05.008-Not Available
Nausea07.01.07.001--
Nephrogenic diabetes insipidus20.05.03.010; 14.05.07.002-Not Available
Nephropathy20.05.03.001-Not Available
Nephropathy toxic12.03.01.010; 20.05.03.002-Not Available
Nervous system disorder17.02.10.001-Not Available
Neuroleptic malignant syndrome17.05.02.003; 15.05.04.015; 12.03.01.003; 08.05.01.005-Not Available
Neurotoxicity17.02.10.002; 12.03.01.011-Not Available
Neutropenia01.02.03.004--Not Available
Neutrophil count decreased13.01.06.010-
The 5th Page    First    Pre   5 6 7 8 9    Next   Last    Total 10 Pages